CD38 and infection: Also, patients with advanced clinical stage, unmutated IGHV, genetic abnormalities [TP53 mutation or deletion, ATM mutation or deletion, tris(12)] and those with CD38 positivity had a shorter time-to-first major infection, with both stage and IGHV mutational status maintaining their independent value in multivariate analysis.